S100A10 and cancer: Kaplan–Meier survival analysis showed that high levels of S100A10 were significantly associated with both shorter overall survival (HR = 3.34, p < 0.0001) and recurrence-free cancer (HR = 2.27, p < 0.001) (Figure 7A,B).